Hemofiltration is evolving as an adjunctive therapy for sepsis and other forms of systemic inflammation. Designed as a substitute for lost renal function, it is sometimes employed prior to the onset of renal failure to facilitate the nonspecific clearance of pro-inflammatory mediators. Prevailing theories suggest that hemofiltration attenuates the immune response when a threshold amount of excess cytokine is removed at the semi-permeable membrane. In this article we introduce an alternative hypothesis, in which hemofiltration exerts its effect by reinvigorating lymphatic flow and function. Crystalloid “replacement” solution, as much as 48 to 72 liters daily, is infused to restore intravascular volume lost through production of ultrafiltrate. Partial redistribution into interstitium and lymph mobilizes inflammatory mediators and other proteins, cellular byproducts, excessive ground matrix, fragments of apoptotic cells and free DNA. These substances are then metabolized, scavenged or cleared at multiple sites, including the reticuloendothelial system, liver, kidney, erythrocyte, and hemofilter.
De VrieseA.S., ColardynF.A., PhilippeJ.J., VanholderR.C., De SutterJ.H., LameireN.H.Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol1999; 10: 846–53.
3.
GohlH., BuckR., StrathmannH.Basic features of the polyamide membranes. Contrib Nephrol1992; 96: 1–25.
4.
BellomoR., TippingP., BoyceN.Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail1995; 17: 457–66.
5.
HeeringP., MorgeraS., SchmitzF.J.Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med1997; 23: 288–96.
6.
ColeL., BellomoR., DavenportP., TippingP., RoncoC.Cytokine removal during continuous renal replacement therapy: An ex vivo comparison of convection and diffusion. Int J Artif Organs2004; 27: 388–97.
7.
UchinoS., BellomoR., GoldsmithD.Cytokine removal with a large pore cellulose triacetate filter: An ex vivo study. Int J Artif Organs2002; 25: 27–32.
8.
RoncoC., TettaC., MarianoF.Interpreting the mechanisms of continuous renal replacement therapy in sepsis: The peak concentration hypothesis. Artif Organs2003; 27: 792–801.
9.
Di CarloJ.V., AlexanderS.R., AgarwalR., SchiffmanJ.D.Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol2003; 25: 801–5.
10.
AsachenkovA.L., MarchukG.I., MohlerR.R., ZuevS.M.Immunology and disease control: A systems approach. IEEE Trans Biomed Eng1994; 41: 943–53.
11.
HonoreP.M., Joannes-BoyauO.High volume hemofiltration (HVHF) in sepsis: A comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs2004; 27: 1077–82.
12.
HonoreP.M., MatsonJ.R.Extracorporeal removal for sepsis: Acting at the tissue level–the beginning of a new era for this treatment modality in septic shock. Crit Care Med2004; 32: 896–7.
13.
KashiwazakiM., TanakaT., KandaH.A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol2003; 15: 1219–27.
14.
DalbethN., GundleR., DaviesR.J., LeeY.C., McMichaelA.J., CallanM.F.CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol2004; 173: 6418–26.
15.
SairM., EtheringtonP.J., Peter WinloveC., EvansT.W.Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med2001; 29: 1343–9.
16.
CastellJ.V., GeigerT., GrossV.Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem1988; 177: 357–61.
17.
ParkerJ.C., RippeB., TaylorA.E.Fluid filtration and protein clearances through large and small pore populations in dog lung capillaries. Microvasc Res1986; 31: 1–17.
18.
KimuraG., IrieA., KurodaK., KojimaS., SataniM.Absence of transcellular fluid shift during haemofiltration. Proc Eur Dial Transplant Assoc1980; 17: 192–6.
19.
HenriksenJ.H., ParvingH.H., LassenN.A., WinklerK.Increased transvascular escape rate and lymph drainage of albumin in pigs during intravenous diuretic medication. Relations to treatment in man and transport mechanisms. Scand J Clin Lab Invest1982; 42: 423–9.
20.
WallaceJ.R., BellD.R.Comparison of protein lymph flux and extravascular uptake in skin during increased venous pressure. Am J Physiol1992; 263: H895–902.
21.
GandhiR.R., BellD.R.Influence of saline infusions on transvascular protein transport. Am J Physiol1992; 262: H443–50.
22.
WassermanK., MayersonH.S.Mechanism of plasma protein changes following saline infusions. Am J Physiol1952; 170: 1–10.
23.
WassermanK., MayersonH.S.Dynamics of lymph and plasma protein exchange. Cardiologia1952; 21: 296–307.
24.
SmebyL.C., CharltonB., SchindhelmK.Kinetics of intravenous saline infusion and selective IgG removal in rabbits. Am J Physiol1984; 247: R816–26.
25.
CharltonB., SchindhelmK., SmebyL.C., FarrellP.C.Analysis of immunoglobulin G kinetics in the non-steady state. J Lab Clin Med1985; 105: 312–20.
26.
OnarheimH., MissavageA.E., GuntherR.A., KramerG.C., ReedR.K., LaurentT.C.Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res1991; 50: 259–65.
27.
OlszewskiW.L.The lymphatic system in body homeostasis: Physiological conditions. Lymphat Res Biol2003; 1: 11–21.
28.
SanderA., ArmbrusterW., SanderB., DaulA.E., LangeR., PetersJ.Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med1997; 23: 878–84.
29.
NobleP.W.Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol2002; 21: 25–9.
30.
TederP., VandivierR.W., JiangD.Resolution of lung inflammation by CD44. Science2002; 296: 155–8.
31.
HallgrenR., SamuelssonT., LaurentT.C., ModigJ.Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis1989; 139: 682–7.
32.
LiuN.Metabolism of macromolecules in tissue. Lymphat Res Biol2003; 1: 67–70.
33.
BergS., GolsterM., LisanderB.Albumin extravasation and tissue washout of hyaluronan after plasma volume expansion with crystalloid or hypooncotic colloid solutions. Acta Anaesthesiol Scand2002; 46: 166–72.
34.
BeutlerB.A., MilsarkI.W., CeramiA.Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo. J Immunol1985; 135: 3972–7.
35.
CapperS.J., KalinkaS., ManderT.H.Specific radio-immunoassays for IL 1 alpha and IL 1 beta in plasma at physiological and acidic pH: Determination of immunoreactive forms by gel filtration and radioligand binding studies. Cytokine1990; 2: 182–9.
36.
NewtonR.C., UhlJ., CovingtonM., BackO.The distribution and clearance of radiolabeled human interleukin-1 beta in mice. Lymphokine Res1988; 7: 207–16.
37.
BinoT., MadarZ., GertlerA., RosenbergH.The kidney is the main site of interferon degradation. J Interferon Res1982; 2: 301–8.
38.
FerraioloB.L., FullerG.B., BurnettB., ChanE.Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration. J Biol Response Mod1988; 7: 115–22.
39.
CrawfordJ.H., YangS., ZhouM., SimmsH.H., WangP.Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med2004; 32: 502–8.
40.
DeaciucI.V., AlappatJ.M., McDonoughK.H., D'SouzaN.B.Effect of chronic alcohol consumption by rats on tumor necrosis factor-alpha and interleukin-6 clearance in vivo and by the isolated, perfused liver. Biochem Pharmacol1996; 52: 891–9.
41.
PuneetP., MoochhalaS., BhatiaM.Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol2005; 288: L3–L15.
42.
DawsonT.C., LentschA.B., WangZ.Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood2000; 96: 1681–4.
43.
SvensenC.H., BrauerK.P., HahnR.G.Elimination rate constant describing clearance of infused fluid from plasma is independent of large infusion volumes of 0.9% saline in sheep. Anesthesiology2004; 101: 666–74.
44.
RoncoC., BellomoR., HomelP.Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet2000; 356: 26–30.
45.
StahleL., NilssonA., HahnR.G.Modelling the volume of expandable body fluid spaces during i.v. fluid therapy. Br J Anaesth1997; 78: 138–43.
46.
KellenM.R., BassingthwaighteJ.B.An integrative model of coupled water and solute exchange in the heart. Am J Physiol Heart Circ Physiol2003; 285: H1303–16.
47.
BoumanC.S., van OldenR.W., StoutenbeekC.P.Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif1998; 16: 261–8.
48.
van BommelE.F., HesseC.J., JutteN.H., ZietseR., BruiningH.A., WeimarW.Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Ren Fail1997; 19: 443–54.
49.
HonoreP.M., MatsonJ.R.Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care2002; 6: 394–6.
50.
KandusA., PonikvarR., DrinovecJ., PavlinK., IvanovichP.Beta 2-microglobulin elimination characteristics during hemofiltration with acrylonitrile and polysulfone membrane hemofilters. Int J Artif Organs1990; 13: 200–4.
51.
UchinoS., ColeL., MorimatsuH., GoldsmithD., RoncoC., BellomoR.Solute mass balance during isovolaemic high volume haemofiltration. Intensive Care Med2003; 29: 1541–6.
52.
ChoiG., GomersallC.D., LipmanJ.The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration an in vitro study of levofloxacin. Int J Antimicrob Agents2004; 24: 468–72.
TownsleyM.I., ReedR.K., IshibashiM., ParkerJ.C., LaurentT.C., TaylorA.E.Hyaluronan efflux from canine lung with increased hydrostatic pressure and saline loading. Am J Respir Crit Care Med1994; 150: 1605–11.
